色素障害治療市場：適応症別、治療法別、エンドユーザー別-2025-2030年の世界予測

色素障害治療市場は、2023年に67億8,000万米ドルと評価され、2024年には72億8,000万米ドルに達すると予測され、CAGR 7.42％で成長し、2030年には112億1,000万米ドルに達すると予測されています。

色素障害治療市場には、メラニンの過剰産生、ホルモンバランスの乱れ、遺伝的条件などの要因によって引き起こされる皮膚の色調異常を修正することを目的とした治療法やソリューションが含まれます。この市場は、美肌に対する需要の高まりと、肝斑、白斑、色素沈着のような色素沈着疾患の有病率の増加により、大きな必要性を持っています。用途としては、主に皮膚科医や美容クリニックで使用される局所軟膏、レーザー治療、ケミカルピーリング、薬剤介入などがあります。最終用途の範囲は、医療施設と、美容とウェルネスに焦点を当てた直接消費者向けスキンケアブランドの両方に広がっています。

市場の成長は、皮膚科学技術の進歩と皮膚の健康に対する消費者の意識の高まりによって後押しされています。新興国における可処分所得の増加やセルフケア志向の高まりは、治療オプションの普及率上昇につながっています。さらに、より効果的で侵襲性の低い治療法の開拓は、市場拡大の大きなチャンスとなっています。しかし、高度な治療には高額な費用がかかること、普遍的な保険が適用されないこと、副作用の可能性があることなどの制約が課題となっています。さらに、製品の入手可能性や患者の治療へのアクセスには地域差があり、市場は断片化されています。

成長機会を生かすためには、遺伝子治療やバイオエンジニアリングによる皮膚治療など、副作用を最小限に抑え、より早く効果をもたらす次世代治療への投資が必要です。また、個別化や民族に合わせた治療レジメンの調査を強化することも、市場の主導権を握る原動力となります。この市場の性質は競争であり、絶え間ない技術革新、規制当局の監視、技術進歩の速いペースを特徴とします。効果的な市場戦略は、研究開発能力を強化するための戦略的提携、合併、買収に重点を置くべきです。また、若年層をターゲットにした革新的なマーケティングや、デジタルヘルス・プラットフォームの活用も、消費者のエンゲージメントを高め、市場リーチを拡大する可能性があります。

市場力学：急速に進化する色素障害治療市場の主要市場インサイトを公開

色素障害治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • スキンケアの重要性に対する認識と関心の高まり
  • 化粧品やスキンケア製品への支出の増加
  • 研究開発費の増加と積極的なマーケティング戦略
• 市場抑制要因
  • 治療費の高騰と治療結果のばらつき
• 市場機会
  • レーザー治療やニードリングプロセスのような技術の進歩
  • アゼライン酸のような様々な薬剤の進歩
• 市場の課題
  • 皮膚過敏症の増加、アレルギー、一部の薬剤に対する反応

ポーターの5つの力：色素障害治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：色素障害治療市場における外部からの影響の把握

外部マクロ環境要因は、色素障害治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析色素障害治療市場における競合情勢の把握

色素障害治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス色素障害治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、色素障害治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨色素障害治療市場における成功への道筋を描く

色素障害治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • スキンケアの重要性に対する意識と関心の高まり
    • 化粧品やスキンケア製品への支出増加
    • 研究開発費の増加と積極的なマーケティング戦略
  • 抑制要因
    • 治療費が高く、結果もまちまち
  • 機会
    • レーザー治療やニードリングプロセスなどの技術的進歩
    • アゼライン酸などのさまざまな薬の進歩
  • 課題
    • 皮膚の敏感性、アレルギー、および特定の物質に対する反応の増加
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 色素障害治療市場適応症別

• 色素沈着
• 色素沈着低下

第7章 色素障害治療市場治療と療法

• ケミカルピーリング
• 皮膚剥離
• レーザーリサーフェシング
• 肝斑

第8章 色素障害治療市場：エンドユーザー別

• 皮膚科クリニック
• 病院

第9章 南北アメリカの色素障害治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の色素障害治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの色素障害治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Affiliated Dermatology
• Allergan, Inc.
• Derma Med Spa
• EpiPharm AG
• GK Dermatology, PC
• Kaya Limited
• La Roche-Posay by L'Oreal Singapore Pte. Ltd.
• Obagi Cosmeceuticals LLC
• Skin Deep Laser Services
• VIVIER PHARMA USA
• Water's Edge Dermatology

LIST OF FIGURES

• FIGURE 1. PIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPERPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPOPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMABRASION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER RESURFACING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 30. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 47. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 50. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 102. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 114. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 117. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Pigmentation Disorders Treatment Market was valued at USD 6.78 billion in 2023, expected to reach USD 7.28 billion in 2024, and is projected to grow at a CAGR of 7.42%, to USD 11.21 billion by 2030.

The Pigmentation Disorders Treatment market encompasses therapies and solutions aimed at correcting abnormalities in skin coloration caused by factors such as melanin overproduction, hormonal imbalances, or genetic conditions. This market holds significant necessity due to the growing demand for aesthetically pleasing skin and the increasing prevalence of pigmentation disorders like melasma, vitiligo, and hyperpigmentation. Applications include topical ointments, laser therapies, chemical peels, and pharmaceutical interventions primarily used by dermatologists and cosmetic clinics. The end-use scope extends to both medical facilities and direct consumer skincare brands focused on beauty and wellness.

Market growth is bolstered by advancements in dermatological technology and increasing consumer awareness about skin health. Rising disposable incomes in emerging economies and a trend towards self-care are leading to greater adoption rates of treatment options. Moreover, the development of more effective, less invasive treatments offers substantial opportunities for market expansion. However, limitations such as the high cost of advanced treatments, a lack of universal insurance coverage, and the potential for side effects pose challenges. Further, the market is fragmented with regional variances in product availability and patient access to treatments.

To capitalize on growth opportunities, businesses should invest in next-generation therapies that minimize side effects and offer faster results, such as gene therapy and bioengineered skin treatments. Enhancing research into personalized and ethnically-tailored treatment regimens can also drive market leadership. The nature of this market is competitive, characterized by continuous innovation, regulatory scrutiny, and a fast pace of technological advancements. Effective market strategies should focus on strategic partnerships, mergers, and acquisitions to bolster research and development capabilities. Innovative marketing targeting younger demographics and leveraging digital health platforms could also enhance consumer engagement and broaden market reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising awareness and concerns about importance of skincare
  • Growing expenditure on cosmetics and skincare products
  • Rising R&D spending and aggressive marketing strategies
• Market Restraints
  • High cost of treatments and varying output results
• Market Opportunities
  • Technological advancements like laser treatment and needling process
  • Advancements in various drugs like azelaic acid
• Market Challenges
  • Increasing skin sensitivity, allergies and reactions to some

Porter's Five Forces: A Strategic Tool for Navigating the Pigmentation Disorders Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pigmentation Disorders Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pigmentation Disorders Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pigmentation Disorders Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pigmentation Disorders Treatment Market

A detailed market share analysis in the Pigmentation Disorders Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pigmentation Disorders Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pigmentation Disorders Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pigmentation Disorders Treatment Market

A strategic analysis of the Pigmentation Disorders Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pigmentation Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include Affiliated Dermatology, Allergan, Inc., Derma Med Spa, EpiPharm AG, GK Dermatology, PC, Kaya Limited, La Roche-Posay by L'Oreal Singapore Pte. Ltd., Obagi Cosmeceuticals LLC, Skin Deep Laser Services, VIVIER PHARMA USA, and Water's Edge Dermatology.

Market Segmentation & Coverage

This research report categorizes the Pigmentation Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across Hyperpigmentation and Hypopigmentation.
• Based on Treatment & Therapies, market is studied across Chemical Peels, Dermabrasion, Laser Resurfacing, and Melasma.
• Based on End User, market is studied across Dermatology Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness and concerns about importance of skincare
    • 5.1.1.2. Growing expenditure on cosmetics and skincare products
    • 5.1.1.3. Rising R&D spending and aggressive marketing strategies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatments and varying output results
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements like laser treatment and needling process
    • 5.1.3.2. Advancements in various drugs like azelaic acid
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing skin sensitivity, allergies and reactions to some
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pigmentation Disorders Treatment Market, by Indication

• 6.1. Introduction
• 6.2. Hyperpigmentation
• 6.3. Hypopigmentation

7. Pigmentation Disorders Treatment Market, by Treatment & Therapies

• 7.1. Introduction
• 7.2. Chemical Peels
• 7.3. Dermabrasion
• 7.4. Laser Resurfacing
• 7.5. Melasma

8. Pigmentation Disorders Treatment Market, by End User

• 8.1. Introduction
• 8.2. Dermatology Clinics
• 8.3. Hospitals

9. Americas Pigmentation Disorders Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pigmentation Disorders Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pigmentation Disorders Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Affiliated Dermatology
• 2. Allergan, Inc.
• 3. Derma Med Spa
• 4. EpiPharm AG
• 5. GK Dermatology, PC
• 6. Kaya Limited
• 7. La Roche-Posay by L'Oreal Singapore Pte. Ltd.
• 8. Obagi Cosmeceuticals LLC
• 9. Skin Deep Laser Services
• 10. VIVIER PHARMA USA
• 11. Water's Edge Dermatology